MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin
Lupin
BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 24, 17:00
769.80
20.9 (2.79%)
VOLUME 104,054
LIVE
NSE
May 24, 17:00
769.65
21.85 (2.92%)
VOLUME 1,161,692
Earnings News on Lupin
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Indian pharmas gain on N America boost: Q4 earnings review 

8.49 pm | 09 May 2013 |  Source: CNBC-TV18

CNBC-TV18’s Archana Shukla reports that the pharma sector’s fortunes in the January-March quarter were dictated by the US market while the sector'...

Attention to margins, quality doubles Lupin Q4 net: MD 

7.09 pm | 08 May 2013 |  Source: CNBC-TV18

Kamal Sharma, MD, Lupin Ltd says, in an interview to CNBC-TV18, that the attention to margins, quality and control on costs caused fourth-quarter net ...

Lupin beats forecast, Q4 net rises 2.6x to Rs 408 cr 

3.32 pm | 08 May 2013 |  Source: Moneycontrol.com

Lupin's fourth quarter net profit more than doubled to Rs 408 crore, while sales gained 35 percent to Rs 2,537 crore, sending the pharma company's sto...

Lupin Q4: Analysts expect 108% PAT growth at Rs 324 cr 

1.14 pm | 08 May 2013 |  Source: CNBC-TV18

Healthcare firm Lupin will announce its fourth quarter (January-March) earnings on Wednesday. Analysts on an average expect the profit after tax to gr...

Pharma cos likely to post 21% EBITDA growth in Q4: MOST 

1.30 pm | 16 Apr 2013 |  Source: Moneycontrol.com

Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY a...

See 23% margins by FY13 end; Indian biz at 18%: Lupin 

4.38 pm | 31 Jan 2013 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Kamal Sharma, managing director, Lupin gives his reaction on the company's positive Q3 results. The company's results be...

Lupin Q3 beats forecast, profit jumps 43% to Rs 335 cr 

1.55 pm | 31 Jan 2013 |  Source: Moneycontrol.com

Pharmaceutical firm Lupin's consolidated net profit grew by 42.6 percent - better-than-expected - to Rs 335.2 crore in the third quarter of financial ...

Lupin Q3: Analysts expect profit to grow 27% to Rs 299 cr 

11.11 am | 31 Jan 2013 |  Source: CNBC-TV18

Healthcare firm Lupin is set to declare its results for the third quarter of financial year 2012-13 on Thursday. Analysts on an average expect profit ...

1
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.